Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon N G J A Braat

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Seminars in Nuclear Medicine|April 8, 2019
Hepatobiliary Imaging in Liver-directed TreatmentsCaren van Roekel, Margot T M Reinders, Sandra van der Velden, et al.
European Journal of Gastroenterology & Hepatology|December 8, 2016
Radioembolization-induced liver disease: a systematic reviewManon N G J A Braat, Karel J van Erpecum, Bernard A Zonnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2021
Dose-response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastasesSander C Ebbers, Caren van Roekel, Manon N G J A Braat, et al.
EJNMMI Research|January 7, 2017
Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patientsManon N G J A Braat, Hugo W de Jong, Beatrijs A Seinstra, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 31, 2024
Effectiveness and complication rates of high intensity focused ultrasound treatment for abdominal wall endometriosis: A systematic reviewElisabeth R Knorren, Larissa A de Ridder, Ingrid M Nijholt, et al.
Cardiovascular and Interventional Radiology|March 23, 2016
The Caudate Lobe: The Blind Spot in Radioembolization or an Overlooked Opportunity?Manon N G J A Braat, Andor F van den Hoven, Pieter J van Doormaal, et al.
EJNMMI Research|February 2, 2022
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapySander C Ebbers, Tessa Brabander, Margot E T Tesselaar, et al.
European Radiology|April 25, 2016
Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocolAndor F van den Hoven, Manon N G J A Braat, Jip F Prince, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in <sup>90</sup>Y RadioembolizationSandra van der Velden, Manon N G J A Braat, Tim A Labeur, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the LiteratureManon N G J A Braat, Sander C Ebbers, Ahmed A Alsultan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Seminars in Nuclear Medicine|April 8, 2019
Hepatobiliary Imaging in Liver-directed TreatmentsCaren van Roekel, Margot T M Reinders, Sandra van der Velden, et al.
European Journal of Gastroenterology & Hepatology|December 8, 2016
Radioembolization-induced liver disease: a systematic reviewManon N G J A Braat, Karel J van Erpecum, Bernard A Zonnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2021
Dose-response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastasesSander C Ebbers, Caren van Roekel, Manon N G J A Braat, et al.
EJNMMI Research|January 7, 2017
Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patientsManon N G J A Braat, Hugo W de Jong, Beatrijs A Seinstra, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 31, 2024
Effectiveness and complication rates of high intensity focused ultrasound treatment for abdominal wall endometriosis: A systematic reviewElisabeth R Knorren, Larissa A de Ridder, Ingrid M Nijholt, et al.
Cardiovascular and Interventional Radiology|March 23, 2016
The Caudate Lobe: The Blind Spot in Radioembolization or an Overlooked Opportunity?Manon N G J A Braat, Andor F van den Hoven, Pieter J van Doormaal, et al.
EJNMMI Research|February 2, 2022
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapySander C Ebbers, Tessa Brabander, Margot E T Tesselaar, et al.
European Radiology|April 25, 2016
Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocolAndor F van den Hoven, Manon N G J A Braat, Jip F Prince, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in <sup>90</sup>Y RadioembolizationSandra van der Velden, Manon N G J A Braat, Tim A Labeur, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the LiteratureManon N G J A Braat, Sander C Ebbers, Ahmed A Alsultan, et al.
Pageof 3